跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73 条关于
“INC102”
全部
73
临床试验
44
药物
19
机构
0
资讯
10
3个月前
Liminatus Pharma to Acquire InnocsAI in $320 Million Deal, Gaining Next-Generation CAR-T Pipeline for Hematologic and Solid Tumors
去年
GlycoNex Partners with Sterling for GNX102-ADC Clinical Trial Production
去年
GlycoNex Partners with Sterling for GNX102-ADC Clinical Trial Manufacturing
去年
AudioCure Pharma's AC102 Shows Promise in Treating Sudden Hearing Loss
去年
IO102-IO103 Vaccine Plus Pembrolizumab Shows Promise in NSCLC
2年前
IO Biotech's Melanoma Trial of IO102-IO103 Combination Therapy to Continue
2年前
IO102-IO103 Cancer Vaccine Plus Pembrolizumab Shows Promise in Head and Neck Cancer
2年前
IO Biotech's IO102-IO103 Plus Pembrolizumab Shows Promise in Head and Neck Cancer
去年
IO Biotech Completes Enrollment in Phase 2 Trial of IO102-IO103 Cancer Vaccine
25天前
Liminatus Pharma Engages Synex as CRO to Advance IBC101 CD19xCD22 Bivalent CAR-T Therapy in South Korea